IBRX Stock Crashes To Near 9-Month Lows On Q3 Earnings Miss – Retail Says No Way To Escape Further Dilution
ImmunityBio reported a first topline miss in six quarters after Q3 revenue came in at $48.8 million, sharply below Wall Street’s estimate of $59.2 million, according to Fiscal.ai. The biotech firm posted a loss of $0.18 per share, wider than consensus estimates of about a $0.08 per-share loss. Anktiva combined with BCG met the primary … Read more